- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on EGF-R Positive Non-Small Cell Lung Cancer in Singapore
Total 191 results
-
National University Hospital, SingaporeRecruitingNon Small Cell Lung Cancer | EGFR Positive Non-small Cell Lung CancerSingapore
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
National Cancer Centre, SingaporeRecruitingAdvanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore
-
National Cancer Centre, SingaporePfizerActive, not recruitingNSCLC Stage IV | NSCLC Stage IIIB | Recurrent NSCLC | NSCLC Stage IIIC | EGFR Positive Non-Small Cell Lung CancerKorea, Republic of, Hong Kong, Thailand, Singapore, Malaysia
-
National University Hospital, SingaporeUnknownNon Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeCompletedNon Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeCompletedNon Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeUnknownNon-small Cell Lung CancerSingapore
-
National University Hospital, SingaporeUnknownNon Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeMassachusetts General Hospital; AstraZenecaUnknown
-
National Cancer Centre, SingaporeGuardant Health AMEA, Inc.RecruitingNon-small Cell Lung Cancer | ALK-Positive Lung CancerKorea, Republic of, Hong Kong, Malaysia, Singapore
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
National University Hospital, SingaporeTan Tock Seng HospitalUnknownStage III Non-Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeUnknown
-
National University Hospital, SingaporeCompletedBreast Cancer | Non Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeBristol-Myers Squibb; Adagene Inc; Singapore Translational Cancer ConsortiumRecruitingMetastatic Non Small Cell Lung CancerSingapore
-
National University Hospital, SingaporeUnknownPatients With Non-small Cell Lung CancerSingapore
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingNon Small Cell Lung Cancer | Nonsquamous Nonsmall Cell Neoplasm of Lung | Non Small Cell Lung Cancer Metastatic | Sensitizing EGFR Gene MutationUnited States, Korea, Republic of, Singapore, Taiwan
-
National Cancer Centre, SingaporeNational University Hospital, Singapore; Johns Hopkins SingaporeTerminatedNon-Small Cell Lung CancerSingapore
-
National Cancer Centre, SingaporeCompletedNon-Small Cell Lung CancerSingapore
-
National Cancer Centre, SingaporeCompletedNon-Small Cell Lung CancerSingapore
-
Daiichi SankyoActive, not recruitingEGFR L858R | EGFR Exon 19 Deletion | Nonsquamous Non-small Cell Lung CancerKorea, Republic of, United States, Netherlands, Spain, United Kingdom, Japan, Austria, Belgium, Italy, France, Taiwan, Germany, Australia, Singapore, China, Hong Kong, Norway, Canada, Poland, Portugal, Switzerland
-
National University Hospital, SingaporeUnknownBreast Cancer | Gastric Cancer | Prostate Cancer | Non-small Cell Lung Cancer | Solid TumorsSingapore
-
National Cancer Centre, SingaporeNovartisCompleted
-
PfizerCompletedALK-positive Non Small Cell Lung Cancer (NSCLC) and ROS1-positive NSCLCUnited States, Canada, Australia, Taiwan, Singapore, Japan, Korea, Republic of, Spain, Belgium, Switzerland, France, Germany, Hong Kong, Italy
-
Sidney Kimmel Comprehensive Cancer Center at Johns...TerminatedPhase II Study of Itraconazole and Pemetrexed in Patients With Previously Treated Non-Squamous NSCLCRecurrent Non Small Cell Lung CancerUnited States, Singapore
-
Cullinan Therapeutics Inc.RecruitingNon Small Cell Lung Cancer | EGFR Exon 20 MutationUnited States, Taiwan, Spain, Korea, Republic of, Japan, Singapore, Italy, Netherlands, Hong Kong
-
National University Hospital, SingaporeBoehringer IngelheimRecruitingNon-Small Cell Lung Cancer | Epidermal Growth Factor Receptor MutationSingapore
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Completed
-
ArriVent BioPharma, Inc.Allist Pharmaceuticals, Inc.RecruitingAdvanced Non-Small Cell Lung Cancer | Metastatic Non-Small Cell Lung Cancer | EGFR Exon 20 MutationsUnited States, Australia, Spain, France, Italy, China, Japan, Korea, Republic of, Malaysia, Netherlands, Philippines, Singapore, Taiwan, Thailand, Brazil, Israel, United Kingdom
-
National Cancer Centre, SingaporeTerminatedNon-small Cell Lung Cancer | Leptomeningeal Disease | Central Nervous System MetastasesSingapore
-
BayerRecruitingAdvanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationHong Kong, United States, Taiwan, Spain, Belgium, China, Japan, France, Korea, Republic of, Singapore, Poland, Israel, Italy, Netherlands, Portugal, Brazil
-
Novartis PharmaceuticalsCompletedALK-positive Non-small Cell Lung CancerUnited States, France, Italy, United Kingdom, Taiwan, Turkey, Belgium, Germany, Canada, Singapore, Spain, Korea, Republic of, Netherlands, Russian Federation, Brazil, Hong Kong, Australia
-
Hummingbird BioscienceMerck KGaA, Darmstadt, GermanyRecruitingAdvanced or Metastatic Squamous Non-Small Cell Lung CancerAustralia, Singapore
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerTaiwan, Korea, Republic of, Singapore, Thailand, Hong Kong
-
YM BioSciencesCIMYM BioSciencesTerminatedNon-small-cell Lung CancerCanada, United States, Singapore
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Squamous Non Small Cell Lung Cancer | Nonsquamous Non Small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Australia, Singapore, Hong Kong, Canada
-
GlaxoSmithKlineCompletedPathologically Proven Stage I, II and III Non-Small Cell Lung Cancer (NSCLC)Singapore, Korea, Republic of
-
National Cancer Centre, SingaporeCompletedNon-small Cell Lung CancerSingapore
-
Novartis PharmaceuticalsTerminatedNon Small Cell Lung CancerSpain, Singapore, Germany, Switzerland, Australia, France, Italy, United States
-
ETOP IBCSG Partners FoundationHoffmann-La Roche; AstraZenecaActive, not recruitingNon Small Cell Lung Cancer MetastaticIreland, Singapore, Spain, Switzerland, Korea, Republic of, Netherlands
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerHong Kong, Spain, Russian Federation, France, Bulgaria, Germany, Estonia, Italy, Poland, Taiwan, United Kingdom, Singapore, Ireland, Belgium
-
AVEO Pharmaceuticals, Inc.Biodesix, Inc.TerminatedNon-small Cell Lung CancerKorea, Republic of, United States, Australia, Taiwan, Singapore, Hong Kong, Italy
-
Novartis PharmaceuticalsCompletedNon-small-cell Lung CancerCanada, France, Spain, Netherlands, Singapore, Germany, Korea, Republic of, Turkey, United States, Norway
-
ETOP IBCSG Partners FoundationJanssen PharmaceuticalsRecruitingNon Small Cell Lung CancerSpain, France, Switzerland, United Kingdom, Singapore, Italy, Netherlands
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung Cancer | Anaplastic Lymphoma Kinase (ALK)Australia, Spain, Singapore, Italy, United States
-
AstraZenecaParexelRecruitingNon-Small Cell Lung Cancer (NSCLC)Korea, Republic of, Malaysia, Taiwan, Thailand, Hong Kong, Singapore, Canada
-
Novartis PharmaceuticalsActive, not recruitingALK-positive NSCLCBelgium, Spain, Italy, Australia, United States, Hong Kong, Canada, Singapore
-
Merck KGaA, Darmstadt, GermanyCompletedNon-small Cell Lung CancerSpain, Taiwan, Korea, Republic of, Singapore, China, Malaysia, Italy
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore